Procter & Gamble Health Ltd

With reference to the announcement dated January 092023 and in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company is now rescheduled to be held on Sunday February 5 2023 inter alia to consider and approve the unaudited financial results for the quarter ended December 312022.We would like to further inform you that the Board at the said meeting would also consider the declaration of interim dividend for the Financial Year 2022-23. The record date for payment of the Interim dividend if declared at the Board meeting will be Monday February 13 2023.